Skip to main content

Compugen Ltd

CGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001119774

In the last 90 days, Compugen Ltd insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; ARK Invest is the only superinvestor holding it.

Q2 2023 vs. Q1 2023

How the institutions holding Compugen Ltd changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of CGEN: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders6869+1
Shares10.9M11.5M+547.2K (+5.0%)
Value$7.68M$13.1M+$5.40M (+70.3%)

New holders (10)

Institutions that held Compugen Ltd at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to CGEN in Q2 2023
InstitutionSharesValue% of portfolio
Sphera Funds Management Ltd.1,229,808$1.40M0.30%
Northern Trust Corp19,771$22.5K0.00%
Cubist Systematic Strategies, LLC19,018$21.7K0.00%
LPL Financial LLC10,100$11.5K0.00%
Quent Capital, LLC10,080$11.5K0.00%
Ieq Capital, LLC10,000$11.4K0.00%
Citadel Advisors LLC2,563$2.92K0.00%
Addison Advisors LLC2,067$2.36K0.00%
CWM, LLC65$00.00%
Psagot Value Holdings Ltd. / (Israel)133$00.00%

Sold out (9)

Institutions that held Compugen Ltd at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of CGEN in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Vanguard Group Inc109,817$77.1K
Jane Street Group, LLC90,329$63.4K
Millennium Management LLC79,777$56.0K
Claudia M.P. Batlle, CRP (R) LLC35,000$24.6K
Legal & General Group Plc28,302$19.9K
Virtu Financial LLC21,484$15.0K
Defender Capital, LLC.10,000$7.02K
Royal Bank of Canada18$0
Benjamin F. Edwards & Company, Inc.200$0